New hope for kids battling relapsed neuroblastoma
NCT ID NCT07437963
Summary
This study is testing whether adding a new drug called iberdomide to a standard chemotherapy and immunotherapy combination is safe and more effective for children and young adults with neuroblastoma that has come back or stopped responding to prior treatment. The goal is to see if this new combination can better control the cancer. The trial will first find the safest dose and then compare the new combination against the standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.